Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Desmosomal proteins in keratinocytes are a group of cell-adhesion molecules and associated adaptor proteins that form desmosomes—specialized intercellular junctions crucial for providing mechanical strength and stability to the epidermis. Core desmosomal proteins include the transmembrane cadherins (desmogleins and desmocollins) and members of the armadillo family (plakoglobin and plakophilins), which interact with desmoplakin to link the junctional complex to the keratin intermediate filament cytoskeleton[2][3][5]. These structures are essential for maintaining strong cell–cell adhesion in tissues subject to mechanical stress, such as the skin. Defects or autoimmunity against these proteins are implicated in skin blistering diseases (e.g., pemphigus), hereditary disorders (e.g., Darier disease), and certain cardiomyopathies[1][2][6]. Targeting individual desmosomal proteins (such as DSG3 in pemphigus) has therapeutic implications, though the protein complex as a whole is not typically a drug target but rather a critical biological structure. Important note on specificity/accuracy: "Desmosomal proteins in keratinocytes" is not a single molecule or receptor but refers to a family of structurally and functionally interconnected proteins forming the desmosome. For structured data, it is preferable to treat each major component protein (e.g., desmoglein 3, desmocollin 1, plakoglobin, desmoplakin) as an individual target. This entry describes the protein group as a whole, but lack of specificity may limit biomedical or pharmacological utility[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Desmosomal protein (keratinocyte).